471 related articles for article (PubMed ID: 31285360)
1. Nanotechnology based therapeutics for lung disease.
Doroudian M; MacLoughlin R; Poynton F; Prina-Mello A; Donnelly SC
Thorax; 2019 Oct; 74(10):965-976. PubMed ID: 31285360
[TBL] [Abstract][Full Text] [Related]
2. Nanotechnology and nanomedicine: going small means aiming big.
Teli MK; Mutalik S; Rajanikant GK
Curr Pharm Des; 2010 Jun; 16(16):1882-92. PubMed ID: 20222866
[TBL] [Abstract][Full Text] [Related]
3. Nanomedicine for the management of lung and blood diseases.
Buxton DB
Nanomedicine (Lond); 2009 Apr; 4(3):331-9. PubMed ID: 19331540
[TBL] [Abstract][Full Text] [Related]
4. Tiny technology proves big: a challenge at engineering, medicine and pharmaceutical sciences interface.
Mahapatra AK; Murthy PN; Samoju S; Mohapatra AK
Crit Rev Ther Drug Carrier Syst; 2014; 31(1):1-47. PubMed ID: 24579766
[TBL] [Abstract][Full Text] [Related]
5. Nano based drug delivery systems: recent developments and future prospects.
Patra JK; Das G; Fraceto LF; Campos EVR; Rodriguez-Torres MDP; Acosta-Torres LS; Diaz-Torres LA; Grillo R; Swamy MK; Sharma S; Habtemariam S; Shin HS
J Nanobiotechnology; 2018 Sep; 16(1):71. PubMed ID: 30231877
[TBL] [Abstract][Full Text] [Related]
6. Nanomedicine for Cystic Fibrosis.
Ong V; Mei V; Cao L; Lee K; Chung EJ
SLAS Technol; 2019 Apr; 24(2):169-180. PubMed ID: 30707858
[TBL] [Abstract][Full Text] [Related]
7. Exploring state-of-the-art advances in targeted nanomedicines for managing acute and chronic inflammatory lung diseases.
Maurya S; Srivastava R; Arfin S; Hawthorne S; Jha NK; Agrawal K; Raj S; Rathi B; Kumar A; Raj R; Agrawal S; Paiva-Santos AC; Malik AA; Dua K; Rana R; Ojha S; Jha SK; Sharma A; Kumar D; El-Zahaby SA; Nagar A
Nanomedicine (Lond); 2022 Dec; 17(30):2245-2264. PubMed ID: 36975758
[TBL] [Abstract][Full Text] [Related]
8. Nanomedicine: a new frontier in cancer therapeutics.
Lee PY; Wong KK
Curr Drug Deliv; 2011 May; 8(3):245-53. PubMed ID: 21291378
[TBL] [Abstract][Full Text] [Related]
9. Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?
Kateb B; Chiu K; Black KL; Yamamoto V; Khalsa B; Ljubimova JY; Ding H; Patil R; Portilla-Arias JA; Modo M; Moore DF; Farahani K; Okun MS; Prakash N; Neman J; Ahdoot D; Grundfest W; Nikzad S; Heiss JD
Neuroimage; 2011 Jan; 54 Suppl 1(Suppl 1):S106-24. PubMed ID: 20149882
[TBL] [Abstract][Full Text] [Related]
10. Nanomedicine--prospective therapeutic and diagnostic applications.
Emerich DF
Expert Opin Biol Ther; 2005 Jan; 5(1):1-5. PubMed ID: 15709905
[TBL] [Abstract][Full Text] [Related]
11. The importance of reflecting on treatment and post-treatment care when assessing the social aspects of cosmetic nanomedicine and transdermal delivery system.
Duché G; Thordarson P; Kearnes M
Nanomedicine; 2020 Aug; 28():102214. PubMed ID: 32360550
[TBL] [Abstract][Full Text] [Related]
12. Nanomedicine as an innovative therapeutic strategy for pediatric lung diseases.
Tian Y; Chen J; Zahtabi F; Keijzer R; Xing M
Pediatr Pulmonol; 2013 Nov; 48(11):1098-111. PubMed ID: 23997035
[TBL] [Abstract][Full Text] [Related]
13. Nanotechnology and glaucoma: a review of the potential implications of glaucoma nanomedicine.
Kim NJ; Harris A; Gerber A; Tobe LA; Amireskandari A; Huck A; Siesky B
Br J Ophthalmol; 2014 Apr; 98(4):427-31. PubMed ID: 24246373
[TBL] [Abstract][Full Text] [Related]
14. Second world conference on nanomedicine and drug delivery.
Ninan N; Thomas S; George A; Sebastian M
Ther Deliv; 2011 Jun; 2(6):711-5. PubMed ID: 22822503
[TBL] [Abstract][Full Text] [Related]
15. pH-sensitive nano-systems for drug delivery in cancer therapy.
Liu J; Huang Y; Kumar A; Tan A; Jin S; Mozhi A; Liang XJ
Biotechnol Adv; 2014; 32(4):693-710. PubMed ID: 24309541
[TBL] [Abstract][Full Text] [Related]
16. Review of core-multishell nanostructured models for nano-biomedical and nano-biopharmaceutical application.
Šetrajčić-Tomić AJ; Popović JK; Vojnović M; Džambas LD; Šetrajčić JP
Biomed Mater Eng; 2018; 29(4):451-471. PubMed ID: 30282343
[TBL] [Abstract][Full Text] [Related]
17. [The nanotechnology as a support for diagnosis and prognosis in cancer research].
Romero-Morelos P; Peralta-Rodríguez R; Mendoza-Rodríguez M; Valdivia-Flores A; Marrero-Rodríguez D; Paniagua-García L; Rodríguez-Cabrales J; Parra-Melquiádez M; Salcedo-Vargas M
Rev Med Inst Mex Seguro Soc; 2011; 49(6):621-30. PubMed ID: 22176824
[TBL] [Abstract][Full Text] [Related]
18. Nanoinformatics and DNA-based computing: catalyzing nanomedicine.
Maojo V; Martin-Sanchez F; Kulikowski C; Rodriguez-Paton A; Fritts M
Pediatr Res; 2010 May; 67(5):481-9. PubMed ID: 20118825
[TBL] [Abstract][Full Text] [Related]
19. Evaluating Nanomedicines: Obstacles and Advancements.
Swierczewska M; Crist RM; McNeil SE
Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
[TBL] [Abstract][Full Text] [Related]
20. Nanodelivery systems for improved topical antimicrobial therapy.
Basnet P; Škalko-Basnet N
Curr Pharm Des; 2013; 19(41):7237-43. PubMed ID: 23489202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
